Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T94621
|
||||
| Former ID |
TTDI00101
|
||||
| Target Name |
BCAM-AKT2 fusion gene
|
||||
| Gene Name |
AKT2
|
||||
| Synonyms |
PKB beta; Protein kinase B beta; RAC-PK-beta; RAC-beta serine/threonine-protein kinase; AKT2
|
||||
| Target Type |
Research
|
||||
| Function |
Laminin alpha-5 receptor. May mediate intracellular signaling.
|
||||
| BioChemical Class |
Kinase
|
||||
| UniProt ID | |||||
| EC Number |
EC 2.7.11.1
|
||||
| Sequence |
MNEVSVIKEGWLHKRGEYIKTWRPRYFLLKSDGSFIGYKERPEAPDQTLPPLNNFSVAEC
QLMKTERPRPNTFVIRCLQWTTVIERTFHVDSPDEREEWMRAIQMVANSLKQRAPGEDPM DYKCGSPSDSSTTEEMEVAVSKARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAM KILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK KLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSYSASIR E |
||||
| Structure |
1GZK; 1GZN; 1GZO; 1MRV; 1MRY; 1O6K; 1O6L; 1P6S; 2JDO; 2JDR; 2UW9; 2X39; 2XH5; 3D0E; 3E87; 3E88; 3E8D; 2PET; 2PF6
|
||||
| Pathways | |||||
| Reactome | Activation of BAD and translocation to mitochondria | ||||
| GPVI-mediated activation cascade | |||||
| PIP3 activates AKT signaling | |||||
| Translocation of GLUT4 to the plasma membrane | |||||
| Activation of AKT2 | |||||
| AKT phosphorylates targets in the cytosol | |||||
| AKT phosphorylates targets in the nucleus | |||||
| Negative regulation of the PI3K/AKT network | |||||
| AKT-mediated inactivation of FOXO1A | |||||
| Deactivation of the beta-catenin transactivating complex | |||||
| CD28 dependent PI3K/Akt signaling | |||||
| CTLA4 inhibitory signaling | |||||
| gamma signalling through PI3Kgamma | |||||
| VEGFR2 mediated vascular permeability | |||||
| TP53 Regulates Metabolic Genes | |||||
| Constitutive Signaling by AKT1 E17K in Cancer | |||||
| References | |||||
| Ref 527396 | Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett. 2005 Feb 1;15(3):761-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.